Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
36 2. Statement of Assurance<br />
from the Board<br />
<strong>Royal</strong> <strong>Devon</strong> <strong>and</strong> <strong>Exeter</strong> NHS Foundation Trust<br />
Quality <strong>Report</strong> <strong>2012</strong>/<strong>13</strong><br />
Clinical research<br />
participation<br />
Participation in clinical research<br />
demonstrates the Trust’s commitment<br />
to improving the quality of care we<br />
offer <strong>and</strong> to making our contribution<br />
to wider health improvement. Our<br />
clinical staff stay abreast of the latest<br />
treatment possibilities <strong>and</strong> their active<br />
participation in research leads to<br />
successful patient outcomes.<br />
The number of patients receiving<br />
health services provided or subcontracted<br />
by the <strong>Royal</strong> <strong>Devon</strong> &<br />
<strong>Exeter</strong> NHS Foundation Trust in<br />
<strong>2012</strong>/<strong>13</strong> that were recruited during<br />
that period to participate in research<br />
approved by a research ethics<br />
committee was 7,900.<br />
The <strong>Royal</strong> <strong>Devon</strong> & <strong>Exeter</strong> NHS<br />
Foundation Trust is one of the highest<br />
recruiting NHS organisations to clinical<br />
trials in the South West Peninsula. The<br />
Trust was involved in conducting 577<br />
clinical research studies in a wide range<br />
of specialties during <strong>2012</strong>/<strong>13</strong>. During<br />
this period there were over 300 clinical<br />
staff participating in research approved<br />
by a research ethics committee. Over<br />
95% of studies were approved within<br />
30 days of receiving valid application.<br />
The <strong>Royal</strong> <strong>Devon</strong> & <strong>Exeter</strong> NHS<br />
Foundation Trust hosts the Peninsula<br />
Comprehensive Research Network, the<br />
South West Research Design Service <strong>and</strong><br />
the Cancer, Stroke <strong>and</strong> Diabetes Local<br />
Research Networks <strong>and</strong> the Peninsula<br />
Collaboration for Applied Health Research<br />
<strong>and</strong> Care, thus playing a significant role<br />
in the region for the National Institute of<br />
Health Research (NIHR).<br />
The <strong>Royal</strong> <strong>Devon</strong> & <strong>Exeter</strong> NHS<br />
Foundation Trust collaborates with<br />
<strong>Exeter</strong> Medical School, hosting the<br />
NIHR Clinical Research Facility for<br />
experimental medicine. A total of<br />
5500 participants were recruited<br />
into research studies during <strong>2012</strong>/<strong>13</strong><br />
at this facility. Research focuses on<br />
underst<strong>and</strong>ing mechanisms of disease<br />
(mainly in diabetes <strong>and</strong> cardiovascular<br />
patients) <strong>and</strong> introducing<br />
improvements to patient care.<br />
The high quality of the research at<br />
the Trust is demonstrated by the level<br />
of external grant funding, which in<br />
<strong>2012</strong>/<strong>13</strong> exceeded £5 million.<br />
Additionally, in the last three years, 400<br />
publications have resulted from our<br />
involvement in research, evidencing<br />
our commitment to transparency <strong>and</strong><br />
desire to improve patient outcomes<br />
<strong>and</strong> experience across the NHS.<br />
CASE STUDY<br />
Emergency laparotomy – a race<br />
against time<br />
Every year, around 160 patients are<br />
admitted to the RD&E requiring<br />
emergency laparotomy. This group<br />
of patients are often very sick <strong>and</strong><br />
suffer a high rate of morbidity <strong>and</strong><br />
mortality. An audit carried out last<br />
year, by anaesthetists Louise Cossey,<br />
Bruce McCormick <strong>and</strong> James Pittman,<br />
showed that the RD&E’s mortality rate<br />
for these patients was around14%<br />
– slightly better than the national<br />
average, but enough to motivate the<br />
team to seek improvement.<br />
As a result of that initial study, the<br />
Trust will now take part in a<br />
multi-centre pilot of a new care<br />
pathway, launched on 3rd December<br />
<strong>2012</strong>. The pathway follows guidance<br />
on best practice issued by the <strong>Royal</strong><br />
College of Surgeons <strong>and</strong> the<br />
National Confidential Enquiry into<br />
Peri-Operative Deaths (CEPOD). It was<br />
designed by the <strong>Royal</strong> Surrey County<br />
<strong>Hospital</strong> NHS Foundation Trust, which<br />
has one of the lowest mortality rates in<br />
the country for these patients.<br />
“We know that with emergency<br />
laparotomy patients, we’re in a race<br />
against time to make a diagnosis <strong>and</strong><br />
commence life-saving treatment as<br />
soon as possible,” said Dr McCormick.<br />
“The key is to identify these patients<br />
<strong>and</strong> intervene with antibiotics<br />
<strong>and</strong>, where indicated, perform<br />
emergency surgery within six hours<br />
of diagnosis, so that they have the<br />
best chance of recovery. We hope<br />
that by close attention to all aspects<br />
of each patient’s care we can achieve<br />
’incremental gains’ that will result in<br />
improved survival of these patients.”<br />
The new pathway adopts a truly<br />
multi-disciplinary approach, involving<br />
staff from the Emergency Department,<br />
Surgery, Anaesthetics, ICU <strong>and</strong><br />
Radiology. Key to implementation of<br />
the new pathway is the role of the<br />
Trust’s four Physicians’ Assistants in<br />
Anaesthesia, who provide an on-call<br />
support service. The pilot is running<br />
for six months before being evaluated<br />
for its impact on length of hospital<br />
stay <strong>and</strong> mortality rates. If, as hoped,<br />
the results show a drop in mortality<br />
then the pathway will be adapted for<br />
ongoing use.